{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:35:34Z","timestamp":1794123334269,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Fundacao para a Ciencia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejps.2021.105831","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T22:43:25Z","timestamp":1617921805000},"page":"105831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Activation of benzoate model prodrugs by mycobacteria. Comparison with mammalian plasma and liver hydrolysis"],"prefix":"10.1016","volume":"162","author":[{"given":"Em\u00edlia","family":"Valente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6847-4830","authenticated-orcid":false,"given":"Lu\u00eds","family":"Constantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105831_bib0001","doi-asserted-by":"crossref","unstructured":"Batt, S.M., Minnikin, D.E., Besra, G.S., 2020. The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system. https:\/\/doi.org\/10.1042\/BCJ20200194.","DOI":"10.1042\/BCJ20200194"},{"key":"10.1016\/j.ejps.2021.105831_bib0002","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1021\/jm950538t","article-title":"Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters","volume":"39","author":"Bergmann","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2021.105831_bib0003","first-page":"87","article-title":"Physicochemical aspects of the enzymatic hydrolysis of carboxylic esters","volume":"57","author":"Buchwald","year":"2002","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2021.105831_bib0004","unstructured":"Bundgaard, H., 1992. A Textbook of Drug Design and Development, in: Krogsgaard-Larsen P., B.H. (Ed.), Harwood Academic Publishers, Switzerland, pp. 153\u2013160."},{"key":"10.1016\/j.ejps.2021.105831_bib0005","doi-asserted-by":"crossref","unstructured":"Camus, J.-C., Pryor, M.J., Me, C., Cole, S.T., 2002. Re-annotation of the genome sequence of mycobacterium tuberculosis H37Rv, microbiology.","DOI":"10.1099\/00221287-148-10-2967"},{"key":"10.1016\/j.ejps.2021.105831_bib0006","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/jo00874a035","article-title":"Steric effects. 7. Additional V constants","volume":"41","author":"Charton","year":"1976","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejps.2021.105831_bib0007","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1021\/ja00839a047","article-title":"Steric effects. I. Esterification and acid-catalyzed hydrolysis of esters","volume":"97","author":"Charton","year":"1975","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2021.105831_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12718-4","article-title":"Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane","volume":"7","author":"Chiaradia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2021.105831_bib0009","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2021.105831_bib0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0940-2993(99)80010-4","article-title":"Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine","volume":"51","author":"Constantino","year":"1999","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ejps.2021.105831_bib0011","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/jm00020a003","article-title":"Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity","volume":"38","author":"Cynamon","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2021.105831_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-019-0273-7","article-title":"The mycobacterial cell envelope \u2014 a moving target","volume":"18","author":"Dulberger","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2021.105831_bib0013","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1023\/A:1015839109449","article-title":"Structure-metabolism relationships in the hydrolysis of nicotinate esters by rat liver and brain subcellular fractions","volume":"8","author":"Durrer","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2021.105831_bib0014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/00498259209046639","article-title":"Enzymic hydrolysis of nicotinate esters: comparison between plasma and liver catalysis","volume":"22","author":"Durrer","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2021.105831_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mib.2017.11.020","article-title":"Lipid metabolism and its implication in mycobacteria\u2013host interaction","volume":"41","author":"Gago","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejps.2021.105831_bib0016","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1099\/jmm.0.2008\/000786-0","article-title":"Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamide","volume":"57","author":"Gu","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejps.2021.105831_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejps.2021.105831_bib0018","series-title":"Substituent Constants for Correlation Analysis in Chemistry and Biology","author":"Hansch","year":"1979"},{"key":"10.1016\/j.ejps.2021.105831_bib0019","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd4581","article-title":"Predicting drug metabolism: Experiment and\/or computation?","volume":"14","author":"Kirchmair","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2021.105831_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0378-5173(87)90200-6","article-title":"Prodrugs as drug delivery systems. 68. Chemical and plasma-catalyzed hydrolysis of various esters of benzoic acid: a reference system for design prodrug esters of carboxylic acid agents","volume":"39","author":"Nielsen","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2021.105831_bib0021","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1128\/AAC.00936-15","article-title":"Esters of pyrazinoic acid are active against pyrazinamide-resistant strains of Mycobacterium tuberculosis and other naturally resistant mycobacteria in vitro and ex vivo within macrophages","volume":"59","author":"Pires","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2021.105831_bib0022","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejps.2009.02.012","article-title":"Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis","volume":"37","author":"Sim\u00f5es","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105831_bib0023","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/ja01131a010","article-title":"Linear free energy relationships from rates of esterification and hydrolysis of aliphatic and ortho-substituted benzoate esters","volume":"74o","author":"Taft","year":"1952","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2021.105831_bib0024","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/ja01132a049","article-title":"Polar and steric substituent constants for aliphatic and o-Benzoate groups from rates of esterification and hydrolysis of esters","volume":"74","author":"Taft","year":"1952","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2021.105831_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cbdv.200790032","article-title":"The biochemistry of drug metabolism\u2013an introduction: Part 2. Redox reactions and their enzymes","volume":"4","author":"Testa","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejps.2021.105831_bib0026","doi-asserted-by":"crossref","unstructured":"Testa, B., Mayer, J.M., 2006. Hydrolysis in drug and prodrug metabolism: chemistry, biochemistry, and enzymology, hydrolysis in drug and prodrug metabolism: chemistry, biochemistry, and enzymology. wiley. https:\/\/doi.org\/10.1002\/9783906390444.","DOI":"10.1016\/j.ejmech.2005.03.006"},{"key":"10.1016\/j.ejps.2021.105831_bib0027","unstructured":"Valente, E., 2009. Beta lactamas como inibidores de proteases de serina e activa\u00e7\u00e3o de pr\u00f3-f\u00e1rmacos por esterases. Lisbon."},{"key":"10.1016\/j.ejps.2021.105831_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mimet.2011.02.003","article-title":"Development of a method to investigate the hydrolysis of xenobiotic esters by a Mycobacterium smegmatis homogenate","volume":"85","author":"Valente","year":"2011","journal-title":"J. Microbiol. Methods"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:00:33Z","timestamp":1760529633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721001330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"alternative-id":["S0928098721001330"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105831","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of benzoate model prodrugs by mycobacteria. Comparison with mammalian plasma and liver hydrolysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105831"}}